RA
IBB icon

Ransom Advisory’s iShares Biotechnology ETF IBB Stock Holding History

Ransom Advisory’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$84.2K Buy
+499
New +$81K 0.03% 174
2025
Q1 		– Sell
-599
Closed -$79.2K – 358
2024
Q4 		$79.2K Hold
599
– – 0.04% 174
2024
Q3 		$87.2K Hold
599
– – 0.04% 172
2024
Q2 		$82.2K Hold
599
– – 0.04% 169
2024
Q1 		$82.2K Buy
+599
New +$81.8K 0.04% 161

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ransom Advisory's IBB Position: Q4 2025 in Review

Ransom Advisory opened a new position in iShares Biotechnology ETF (IBB) in Q4 2025: 499 shares worth $84.2K. The stake represents 0.03% of the portfolio and ranks #174 among its holdings. This is a return to the name: Ransom Advisory previously reported a position in IBB as recently as Q4 2024.

Ransom Advisory first reported a position in IBB in Q1 2024 and has held it in 5 quarters since. The position peaked at $87.2K in Q3 2024. 956 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Ransom Advisory held 499 shares of iShares Biotechnology ETF worth $84.2K as of Q4 2025.
  • iShares Biotechnology ETF was a new Ransom Advisory position in Q4 2025.
  • iShares Biotechnology ETF made up 0.03% of Ransom Advisory's portfolio in Q4 2025, its #174 holding.
  • Ransom Advisory first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 5 quarters since.
  • Ransom Advisory's iShares Biotechnology ETF position peaked at $87.2K in Q3 2024.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.